|
CN105125511A
|
|
Tenofovir disoproxil fumarate tablet and preparation method thereof
|
|
CN105267173A
|
|
Piribedil sustained-release tablets and preparation method thereof
|
|
CN105012249A
|
|
Injection rifampicin and preparing method thereof
|
|
CN104706603A
|
|
Olanzapine freeze-drying orally disintegrating tablet and preparation method thereof
|
|
CN104705540A
|
|
Lorcaserin hydrochloride jelly and preparation method thereof
|
|
CN104706604A
|
|
Perampanel freeze-dried oral disintegrating tablet and preparation method thereof
|
|
CN104367558A
|
|
Oseltamivir lyophilized orally-disintegrating tablets and preparation method thereof
|
|
CN104173297A
|
|
Dexrazoxane freeze-dried powder injection and preparation method thereof
|
|
CN104173195A
|
|
Fully-automatic freeze-dried tablet production equipment and control method thereof
|
|
CN104161728A
|
|
Chlorinated propionyl-L-carnitine freeze-dried powder injection and preparation method thereof
|
|
CN104069083A
|
|
Nifuratel film-coated tablet and preparation method thereof
|
|
CN103860481A
|
|
Ibandronate sodium freeze-dried powder injection and preparing method thereof
|
|
CN103655478A
|
|
Celecoxib solid dispersion and preparation method and application thereof
|
|
CN103505498A
|
|
Preparation and application of effective part of total flavonoids in fenugreek
|
|
CN103479702A
|
|
Extraction method and application of safflower yellow pigment
|
|
CN102258586B
|
|
Composition for treating rheumatoid arthritis
|
|
CN101926758A
|
|
Itraconazole suppository
|
|
CN101897712A
|
|
Ursodeoxycholic acid phospholipid composition and preparation method thereof
|
|
CN101897771A
|
|
Medicine composition for preventing or treating neurasthenia
|
|
CN101890034A
|
|
Picroside II phospholipid composition and preparation method
|
